These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12581266)

  • 1. Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study.
    Bosnyak Z; Forrest KY; Maser RE; Becker D; Orchard TJ;
    Diabet Med; 2003 Feb; 20(2):147-51. PubMed ID: 12581266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do tissue plasminogen activator-plasminogen activator inhibitor-1 complexes relate to the complications of insulin-dependent diabetes mellitus? Pittsburgh Epidemiology of Diabetes Complications Study.
    Maser RE; Ellis D; Erbey JR; Orchard TJ
    J Diabetes Complications; 1997; 11(4):243-9. PubMed ID: 9201602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO; Abdullah A; Tahzeeb S
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.
    Segarra A; Chacón P; Martinez-Eyarre C; Argelaguer X; Vila J; Ruiz P; Fort J; Bartolomé J; Camps J; Moliner E; Pelegrí A; Marco F; Olmos A; Piera L
    J Am Soc Nephrol; 2001 Jun; 12(6):1255-1263. PubMed ID: 11373350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models.
    Hagiwara H; Kaizu K; Uriu K; Noguchi T; Takagi I; Qie YL; Seki T; Ariga T
    Thromb Res; 2003; 111(4-5):301-9. PubMed ID: 14693179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction.
    Fernhall B; Szymanski LM; Gorman PA; Milani J; Paup DC; Kessler CM
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1106-13. PubMed ID: 9194761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer.
    de Witte JH; Sweep CG; Klijn JG; Grebenschikov N; Peters HA; Look MP; van Tienoven TH; Heuvel JJ; Bolt-De Vries J; Benraad TJ; Foekens JA
    Br J Cancer; 1999 Apr; 80(1-2):286-94. PubMed ID: 10390010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.
    Svendsen OL; Hassager C; Christiansen C; Nielsen JD; Winther K
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):381-5. PubMed ID: 8630663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in diabetic foot syndrome.
    Kulwas A; Lisewska B; Jundziłł W; Ruszkowska B; Drewniak W; Ruprecht Z; Gadomska G; Rość D
    Adv Med Sci; 2017 Mar; 62(1):87-91. PubMed ID: 28193577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ; Wu YH; Liu CF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
    Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels.
    Chandler WL; Alessi MC; Aillaud MF; Henderson P; Vague P; Juhan-Vague I
    Circulation; 1997 Aug; 96(3):761-8. PubMed ID: 9264480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycation does not alter LDL-induced secretion of tissue plasminogen activator and plasminogen activator inhibitor-1 from human aortic endothelial cells.
    Klein RL; Semler AJ; Baynes JW; Thorpe SR; Lyons TJ; Jenkins AJ
    Ann N Y Acad Sci; 2005 Jun; 1043():379-89. PubMed ID: 16037259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.